Skip to main content

Table 2 Costs of care in the baseline and programme periods

From: Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme

 

Pre-Programme1

 

Programme2

 

Change3,4

   
 

Mean

(SD)

Mean

(SD)

Mean

95% CI4

N

p

Cost (£, 2011)

        

Programme

  

32.00

-

32.00

-

-

-

Emollient [A]

9.29

(9.30)

19.57

(12.03)

10.28

(7.93 to 12.64)

132

0.001

Emollient [B]

9.72

(9.69)

22.64

(12.21)

12.91

(10.72 to 15.10)

115

0.001

GP visits

68.53

(76.70)

30.40

(31.67)

-38.13

(-52.58 to -23.68)

135

0.001

Overall cost [A]

78.29

(79.34)

82.66

(34.16)

4.37

(-10.55 to 19.30)

132

0.62

Overall cost [B]

80.32

(82.48)

84.37

(31.29)

4.06

(-12.00 to 20.11)

115

0.56

  1. 1 Estimated for the 12 weeks preceding intervention, using 2 week baseline data and 12 week recall (GP visits).
  2. 2 Twelve weeks while receiving the patient support programme.
  3. 3 Difference in costs in the two periods (negative denotes a reduction).
  4. 4 Estimated by bootstrapping with 1,000 replications.
  5. A Emollient use costed using the daily diary method.
  6. B Emollient use costed using the estimated time taken to use a 500 g pot of emollient.
Back to article page

BMC Dermatology

ISSN: 1471-5945

Contact us